YOU SEARCHED BY...
SEARCH BY...
States
- Alabama(1)
- California(2)
- Florida(1)
- Illinois(2)
- Indiana(1)
- Kentucky(1)
- Maryland(2)
- Michigan(1)
- Minnesota(1)
- Missouri(2)
- New Jersey(10)
- New York(2)
- Ohio(1)
- Pennsylvania(2)
- Tennessee(3)
- Texas(1)
- Utah(1)
- Washington(1)
- Wisconsin(1)
Contract Service Directory
ANI Pharmaceuticals
Company Headquarters
210 Main St. W.
Baudette, MN 56623
United States
Contract Service Directory
- Accelerated Stability Studies
- Analytical Laboratory Services
- Analytical Methods Development
- Assay Development
- Blending
- Contract Development and Manufacturing Organization (CDMO)
- Contract Manufacturing
- Dissolution Testing
- Dosage Form Development
- Fluid Bed Processing
- Granulation
- Lot Release Testing
- Manufacturing, Capsules
- Manufacturing, Controlled Substances
- Manufacturing, Creams & Ointments
- Manufacturing, Cytotoxic & High Potency Compounds
- Manufacturing, Dose Form, Non-Sterile
- Manufacturing, Ethical
- Manufacturing, Generics
- Manufacturing, High Containment Operations
- Manufacturing, Liquids
- Manufacturing, Orally Dispersible Tablet
- Manufacturing, Semisolids
- Manufacturing, Solid Dosage
- Manufacturing, Solutions & Suspensions
- Manufacturing, Sustained Release
- Manufacturing, Tablets
- Manufacturing, Topicals
- Methods Development
- Microbiological Testing
- Mixing & Blending
- Packaging, Blister
- Packaging, Capsules
- Packaging, Creams & Ointments
- Packaging, Liquids
- Packaging, Powders
- Packaging, Solid Dosage
- Packaging, Tubes
- Packaging, Unit Dosage
- Particle Size Analysis
- Process Development/Scale-Up Services
- QA/QC
- Stability Studies
- Tablet Coating
- Technology Transfer
- Water Testing: Microbiology
Related Content
-
-
Breaking News | Industry News
ANI Acquires Branded Products Portfolio from Sandoz
Enter multi-year manufacturing and supply agreement.Charles Sternberg, Assistant Editor 04.07.21
-
Breaking News | Industry News | Promotions & Moves
Alcami Names Patrick D. Walsh as Chairman and CEO
35-year pharmaceutical industry veteran brings deep industry expertise and a track record of building successful, client-centric, growth organizations.Tim Wright, Editor, Contract Pharma 03.19.21
-
Promotions & Moves
Alcami Appoints Patrick D. Walsh as Chairman and Chief Executive Officer
He succeeds Walter J. Kaczmarek III, who is stepping down as Chief Executive Officer.
-
Breaking News | Industry News
ANI Pharmaceuticals Strengthens CDMO Business
Acquisition of Novitium Pharma for $163.5 million also bolsters R&D engine and generics portfolio.Tim Wright, Editor, Contract Pharma 03.11.21
-
Breaking News | Collaborations & Alliances | Supply Chain
Schreiner MediPharm, PragmatIC Form Partnership for Smart Pharma Labels
New RFID-labels ideal for broad array of pharmaceutical products and medical devices.Schreiner MediPharm 12.11.19
-
Analytical Services | Industry News | QA/QC
Recipharm Launches Recipharm Analytical Solutions
Stand-alone service offers analytical services including method development, method validation, and stability program design and implementation11.04.19
-
Breaking News | cGMP Manufacture | Industry News
ANI Launches New CDMO Brand ANI Global Source
Following the integration of WellSpring, the specialty CDMO will support late stage development and commercial manufacture of pharmaceutical products.10.29.19
-
PPD Expands Bioanalytical Lab Capabilities
Expansion includes growing the lab’s immunochemistry and biomarker space by 8,000 square feet09.19.19
-
Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Catalent, Acura Enter Clinical Manufacturing Pact
Catalent to scale-up manufacturing of LTX-03 for clinical testing09.16.19
-
Simplifying Recombinant Protein Production: Breaking Down the Corynex Protein Expression System
The rise of biologics is having a dramatic impact on how physicians treat many serious and chronic illnesses.
-
Biologics, Proteins, Vaccines | Drug Delivery | Injectables
Growth in Biologics and Maintaining Patient Satisfaction
Vicki A. Barbur of Battelle discusses the driving forces for biologics, the challenges, and new delivery methodsKristin Brooks, Contrct Pharma 08.09.19
-
Trials & Filings
La Jolla Pharma Receives Orphan Designation for Malaria Treatment
LJPC-0118, artesunate, demonstrated to be superior to quinine in reducing mortality in patients with falciparum malaria infection07.23.19
-
Packaging & Tracking | Serialization | Supply Chain
TraceLink, Excellis Partner to Provide Local Track and Trace Services in Russia
Aims to help pharma companies engage with local Russia teams and comply with Russian track and trace requirements07.18.19
-
cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News
GSK Opens Two Mfg. Facilities in Singapore
Invests $95 million for continuous manufacturing to shorten timelines to produce daprodustat07.09.19
-
Breaking News | Industry News | Injectables
ANI Pharmaceuticals Expands Generic Pipeline
Acquires seven development stage drug products from Coeptis06.18.19
-
cGMP Manufacture | Industry News
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News
ANI Pharmaceuticals to Aquire Portfolio of Products
Through agreement with Amneal and Impax for an undisclosed cash consideration, with a $1.7B estimated market value05.01.18
-
Collaborations & Alliances | Drug Development | Industry News
ANI Acquires ANDAs from IDT
ANI paid $2.6 million and a limited single-digit royalty for one product for the 23 previously marketed generic drug products04.04.18
-
Breaking News | Collaborations & Alliances | Industry News | Promotions & Moves
ANI Acquires Marketing Rights from AstraZeneca for $46.5M
The U.S. rights are to market ATACAND, ATACAND HCT, ARIMIDEX, and CASODEX01.02.18
-
Breaking News | cGMP Manufacture | Industry News | Solid Dosage/Creams/Ointments
ANI Launches Indapamide Tablets
Company continues to leverage U.S.-based manufacturing assets04.20.17
-
Promotions & Moves
ANI Appoints Regulatory Affairs VP
Dr. Quinn brings more than 30 years of leadership experience in Global Regulatory Affairs01.17.17
-
Breaking News | Industry News
ANI Launches Lithobid Generic
Lithium Carbonate Extended Release Tablets, 300mg, is an authorized generic of Lithobid12.28.16
-
Breaking News | Capsules | Industry News
ANI Gets FDA Approval For First Generic Competitor to Nilandron
Announces immediate launch of nilutamide tablets07.19.16
-
Capsules | Drug Delivery | Injectables | Supply Chain
-
Drug Development | Promotions & Moves
ANI Appoints Product Development VP
Ginski brings 20 years of experience in API and drug product development05.24.16
-
Industry News | Vials
-
Breaking News | Capsules | Industry News
-
Industry News
ANI Pharma Acquires Two NDAs from Merck for $75M
Adds purified corticotropin gel and corticotropin zinc hydroxide to its portfolio01.06.16
-
Capsules | Industry News
ANI Pharmaceuticals Launches Vancomycin Capsules
IMS Health says U.S. market for Vancomycin HCl Capsules is roughly $113 million11.02.15
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
ANI Pharma Acquires Two Merck NDAs for $75M
Acquisition advances ANI’s core strategy of re-commercializing previously approved products09.21.15
-
Breaking News | Industry News
ANI, IDT Ink U.S. Generic Commercialization Pact
ANI expands marketed generic product portfolio08.12.15
-
Breaking News | Industry News | Solid Dosage/Creams/Ointments
ANI Pays $25mn for Part of Teva’s Generics Portfolio
Includes 19 solid-oral dosage products, and 3 oral suspension products07.15.15
-
Bioassay Development | Breaking News | Drug Development | Financial Reports | Methods Development | Process Development | Toxicology
-
Breaking News | Extractables and Leachables | Facilities | GMPs/GCPs | Inspections | Methods Development | Process Development | Promotions & Moves | QA/QC | Validation
-
Bioassay Development | Breaking News | Capsules | Drug Development | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Methods Development | Process Development | Toxicology
ANI Pharma Expands Sofgen Development Pact
Sofgen to develop, manufacture generic soft gel drug product05.01.14
-
Breaking News | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Process Development
ANI, Sterling Enter Generic Drug Pact
ANI to provide commercial manufacturing servicesKristin Brooks 01.06.14
-
Breaking News | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Industry News | Lyophilization | Process Development
ANI Acquires Generic Drugs from Teva
Gains 31 marketed products for $12.5 million in cashKristin Brooks 12.30.13
-
Breaking News | Capsules | Collaborations & Alliances | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Lyophilization | Process Development
-
Breaking News | Financial Reports
-
Bioassay Development | Breaking News | Drug Development | Industry News | Methods Development | Process Development | Toxicology
BioSante, ANI Complete Merger
Creates integrated specialty branded and generic pharma company06.24.13
-
Breaking News | Industry News
-
Breaking News | Capsules | Extractables and Leachables | Facilities | Fill/Finish | GMPs/GCPs | Lyophilization | Methods Development | Process Development | QA/QC | Validation
